The global “biobanking market Share” is set to gain traction from the rising integration of innovative technologies in the pre-existing systems. Besides, the introduction to virtual biobanking is set to revolutionize the system by enabling researchers to conduct their studies smoothly, as well as by lowering the time constraints. This information is published by Fortune Business Insights™ in a recent study, titled, “Biobanking Market Size, Share & Industry Analysis, By Sample Storage (Blood, Cells & Tissue, and Others), By Application (Regenerative Medicines, Life Sciences, and Others), By Settings (Academic Medical Institutes, and Pharmaceutical & Biotechnology Companies), and Regional Forecast, 2019-2026.”
The study further mentions that the biobanking market size was USD 25.09 billion in 2018 and is projected to reach USD 49.46 billion by 2026, exhibiting a CAGR of 8.9% during the forecast period.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/biobanking-market-102073
The report covers:
- Global Biobanking Market trends, with detailed analysis on consumer trends & manufacturer trends.
- Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
- Key areas of investments identifying market opportunities and challenges in forecast timeframe.
- Competitive analysis of the industry players along with the overview on strategic management.
- Comprehensive company profiles of the major industry players.
Leading Players operating in the Biobanking Market are:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
- Medizinische Universität Graz
- UK Biobank
- Shanghai Zhangjiang Biobank
- Isenet Biobanking
- Hamilton Company
- Thermo Fisher Scientific Inc.
- ProMedDx
- BBL
- Brooks Life Sciences
- ASKION
- Others
High Demand for Samples from Pharmaceutical Industry to Augment Blood Segment
In terms of sample storage, the market is segregated into cells and tissue, blood, and others. Out of these, the blood segment acquired 79.5% biobanking market share in 2018 and is set to lead throughout the forecast period. This is attributable to the rising distribution, storage, and collection of blood samples backed by the increasing cases of infectious diseases. It is further creating high demand for curative measures. As blood samples contain RNA and DNA, they are considered to be a vital biospecimen and hence, are utilized in conducting several research activities. These are especially demanded by the academic medical institutions, as well as many pharmaceutical companies.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/biobanking-market-102073
Emergence of Cord Blood Stem Cell Biobanking to Accelerate Growth
Nowadays, cord blood is considered to be an important source of stem cells that is often processed and conserved for medical research. In the field of biobanking, the conservation of cord blood is gaining more popularity. Also, the upsurging trend of cord blood stem cell biobanking is set to affect the biobanking market growth positively during the forthcoming years. Sweden’s Lund University, for instance, unveiled the world’s largest stem cell biobanking that would aid researchers in understanding the origin and cause of diseases, such as Parkinson’s and Alzheimer’s. Apart from that, the rising incidence of chronic diseases across the globe would contribute to the market growth.
Detailed Table of Content:
- Introduction
- Others Scope
- Market Segmentation
- Others Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Overview: Trends in Biobanking Market
- Prevalence of Key Diseases – By Key Countries
- Overview: Number of Biobanks – By Key Countries
- Key Industry Developments – Mergers, Acquisitions, and Partnerships
- Global Biobanking Market Analysis, Insights and Forecast, 2015-2026
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Sample Storage
- Blood
- Cells & Tissues
- Others
- Market Analysis, Insights and Forecast – By Application
- Regenerative Medicines
- Life Science
- Others
- Market Analysis, Insights and Forecast – By Settings
- Academic Medical Institutions
- Pharmaceutical & Biotechnology Companies
- Market Analysis, Insights and Forecast – By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- North America Biobanking Market Analysis, Insights and Forecast, 2015-2026
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Sample Storage
- Blood
- Cells & Tissues
- Others
- Market Analysis, Insights and Forecast – By Application
- Regenerative Medicines
- Life Science
- Others
- Market Analysis, Insights and Forecast – By Settings
- Academic Medical Institutions
- Pharmaceutical & Biotechnology Companies
- Market Analysis, Insights and Forecast – By Country
- U.S.
- Canada
Continue….
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/biobanking-market-102073
Report Focus:
- Extensive product offerings
- Customer research services
- Robust research methodology
- Comprehensive reports
- Latest technological developments
- Value chain analysis
- Potential Biobanking Market opportunities
- Growth dynamics
- Quality assurance
- Post-sales support
- Regular report updates
Reasons to Purchase this Report:
- Comprehensive analysis of the Biobanking Market growth drivers, obstacles, opportunities, and other related challenges.
- Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
- Identifies market restraints and boosters.
- Identifies all the possible segments present in the market to aid organizations in strategic business planning.
Related Reports:
Immune Health Supplements Market
Healthcare Asset Management Market
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
